Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer.

Schlick, K; Markus, S; Huemer, F; Ratzinger, L; Zaborsky, N; Clemens, H; Neureiter, D; Neumayer, B; Beate, AS; Florian, S; Martin, V; Grundbichler, M; Weiss, L; Melchardt, T; Greil, R; Egle, A. Pancreatology. 2021 Sep 8;S1424-3903(21)00568-8. doi: 10.1016/j.pan.2021.09.004. Online ahead of print.

Expert Discussion: Immunotherapy in Breast Cancer – Ready for Prime Time?

Rinnerthaler, G; Müller, V; Balic, M; Zaman, K; Dieci, MV. Breast Care (Basel). 2021 Apr;16(2):188-191. doi: 10.1159/000515746. Epub 2021 Mar 26.

Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study.

Greil, R; Tedeschi, A; Moreno, C; Anz, B; Larratt, L; Simkovic, M; Gill, D; Gribben, JG; Flinn, IW; Wang, ZY; Cheung, LWK; Nguyen, AN; Zhou, C; Sty-les, L; Demirkan, F. Ann Hematol. 2021 Jul;100(7):1733-1742. doi: 10.1007/s00277-021-04536-6. Epub 2021 May 20.

Disease-related blood-based differential methylation in cystic fibrosis and its representation in lung cancer revealed a regulatory locus in PKP3 in lung epithelial cells.

Schamschula, E; Lahnsteiner, A; Assenov, Y; Hagmann, W; Zaborsky, N; Wiederstein, M; Strobl, A; Stanke, F; Muley, T; Plass, C; Tummler, B; Risch, A. Epigenetics. 2021 Aug 20;1-24. doi: 10.1080/15592294.2021.1959976. Online ahead of print.

Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia af-ter Chimeric Antigen Receptor T-Cell Therapy.

Kiem, D; Leisch, M; Neureiter, D; Haslauer, T; Egle, A; Melchardt, T; Topp, MS; Greil, R. Int J Mol Sci. 2021 May 21;22(11):5449. doi: 10.3390/ijms22115449.

Selective Activation of CNS and Reference PPARGC1A Promoters Is As-sociated with Distinct Gene Programs Relevant for Neurodegenerative Diseases.

Kwik, M; Hainzl, S; Oppelt, J; Tichy, B; Koller, U; Bernardinelli, E; Steiner, M; Zara, G; Nofziger, C; Weis, S; Paulmichl, M; Dossena, S; Patsch, W; Soyal, SM. Int J Mol Sci. 2021 Mar 24;22(7):3296. doi: 10.3390/ijms22073296.

Conventional versus reverse sequence of neoadjuvant epirubi-cin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.

Bartsch, R; Singer, CF; Pfeiler, G; Hubalek, M; Stoeger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Muy-Kheng, TM; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M. Br J Cancer. 2021 May;124(11):1795-1802. doi: 10.1038/s41416-021-01284-2. Epub 2021 Mar 24.

Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.

Bartsch, R; Singer, CF; Pfeiler, G; Hubalek, M; Stoeger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Muy-Kheng, TM; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M. Br J Cancer. 2021 May;124(11):1795-1802. doi: 10.1038/s41416-021-01284-2. Epub 2021 Mar 24.

Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT.

Magnes, T; Wagner, SM; Melchardt, T; Weiss, L; Rinnerthaler, G; Huemer, F; Kopp, M; Gampenrieder, SP; Mayrbäurl, B; Füreder, T; Lenger, D; Andel, J; Egle, A; Greil, R. Wien Klin Wochenschr. 2021 Sep 15. doi: 10.1007/s00508-021-01939-3. Online ahead of print.

Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibition.

Kocher, F; Tymoszuk, P; Amann, A; Sprung, S; Salcher, S; Daum, S; Haybaeck, J; Rinnerthaler, G; Huemer, F; Kauffmann-Guerrero, D; Tufman, A; Seeber, A; Wolf, D; Pircher, A. Lung Cancer. 2021 Sep;159:84-95. doi: 10.1016/j.lungcan.2021.06.020. Epub 2021 Jul 16.